CLINICAL_TRIALS
trial_result
· 2015-10-02
Clinical Trial Update: An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)
Summary
An observational study of NeoRecormon (epoetin beta) in cancer patients with anemia has completed and posted results (FAST).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Anemia, Neoplasms | Status: COMPLETED | Results posted: 2015-10-02